• People banner

    People

Paul Arathoon

Partner

Paul specialises in corporate finance, predominantly for public companies. He has a particular focus on the natural resource, financial services and technology sectors.

paul-arathoon

About

Paul specialises in corporate finance, predominantly for public companies. He has a particular focus on the natural resource, financial services and technology sectors. Paul acts on capital market transactions for issuers and brokers on the Main Market and AIM, including debt and other non-equity capital issues. He also advises on public company takeovers both for bidders and targets and has a particular expertise in advising overseas companies on bids for UK companies subject to the Takeover Code. He also regularly provides governance and regulatory advice to listed companies, including in relation to the Market Abuse Regulation and on shareholder and boardroom disputes.

Paul has been named as a “next generation lawyer” in each edition of the Legal 500 since 2017 and as a “noted practitioner” for AIM transactions in Chambers & Partners 2021. In the 2023 edition of the Legal 500 he was named as a Leading Individual, and in the 2024 edition as a Leading Partner, for small and mid-cap equity capital markets transactions.

He also acts for private companies on a range of matters including section shareholder/ board disputes. He is a member of the Quoted Companies Alliance Legal Experts Committee. 

Experience

  • Acting for CareTech Holdings plc on its £870m takeover by Amalfi Bidco Limited
  • Acting for Cake Box on its admission to AIM
  • Acting for Grant Thornton as nominated adviser and Mirabaud Securities as broker to Kropz plc’s AIM IPO
  • Acting for Tremor International on its acquisition by way of scheme of arrangement of AIM listed RhythmOne plc and its subsequent acquisition of Unruly from News International
  • Acting for Avation plc on various equity fundraising rounds by way of placings and open offers

Our thinking

  • Charles Russell Speechlys advises on three secondary fundraises across three different markets

    Paul Arathoon

    News

  • Andrew Collins and Paul Arathoon write for the Evening Standard on London as a listing destination after failed WE Soda IPO

    Andrew Collins

    In The Press

  • Healthcare Business International quotes Paul Arathoon on Babylon Health's new restructuring plan and issues for shareholders

    Paul Arathoon

    In The Press

  • Charles Russell Speechlys advises 7digital on its £19.4 million acquisition by Songtradr

    Paul Arathoon

    News

  • Charles Russell Speechlys advises Caretech Holdings PLC on its proposed £870.3 million take private

    Andrew Collins

    News

  • AIM Market Webinar

    Mark Howard

    Insights

  • Charles Russell Speechlys advises Duke Royalty on royalty financing agreement with Fairmed Healthcare AG

    Paul Arathoon

    News

  • Charles Russell Speechlys advises on Trident Royalties’ US$28m Placing

    Paul Arathoon

    News

  • Charles Russell Speechlys advises Avation plc on £7.5m secondary placing

    Paul Arathoon

    News

  • Charles Russell Speechlys advises 7digital on oversubscribed placing and subscription

    Paul Arathoon

    News

  • Charles Russell Speechlys advises Oracle Power plc on £46.5m placing and subscription deed

    Paul Arathoon

    News

  • Charles Russell Speechlys advises Grant Thornton as nomad and Tamesis, Ashanti and Azure as joint bookrunners on Trident Resources plc’s admission to AIM

    Paul Arathoon

    News

  • Market Abuse Regulation: How we can help you

    Victoria Younghusband

    General Content

Back to top